Health and Wellness
HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The report shows that enterprise AI adoption has surged, with healthcare among the fastest‑growing sectors at 8x year‑over‑year adoption.
According to healthcare leaders, 2025 was a pivotal year for AI and digital health, marked by technological progress, a shifting focus on its role in healthcare and practical use cases driving its adoption.
The company will use the funds to advance product innovation, strengthen clinical partnerships and accelerate its nationwide growth.
The partnership will allow employers to purchase Noom directly through the healthcare navigation company beginning in the first quarter of 2026.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.